Effect of Olmesartan Medoxomil on Arterial Stiffness and Thickness in Subjects With Metabolic Syndrome.
Phase of Trial: Phase III
Latest Information Update: 25 Jun 2018
At a glance
- Drugs Olmesartan medoxomil (Primary)
- Indications Hypertension
- Focus Registrational; Therapeutic Use
- Acronyms ArtStiff
- Sponsors Daiichi Sankyo Europe
- 17 Jun 2013 Results presented at the 23rd European Meeting on Hypertension.
- 03 Jul 2012 Planned number of patients changed from 318 to 350 as reported by EudraCT.
- 03 Jul 2012 Additional trial locations (France, Netherlands) identified as reported by EudraCT.